Many of the risk-associated SNPs occur in noncoding regions of NRG1, and could alter expression levels14, and both increases and decreases in NRG1/Erb4B levels and/or activity have been found in postmortem studies of schizophrenia patients15–19. The gene discussed is NRG1; the disease is schizophrenia.